Get started
Author

Cèlia Rodríguez-Borjabad

Observed names: C. Borjabad-Rodríguez, C. Rodríguez Borjabad, C. Rodríguez-Borjabad, Celia Rodríguez Borjabad, Celia Rodríguez-Borjabad, Rodríguez Borjabad, Cèlia
Observed institutions: University of Oslo, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas, Centro de Investigación en Red en Enfermedades Cardiovasculares, Institut de Recerca Biomèdica Catalunya Sud, Hospital Universitario Miguel Servet, Centro de Investigación Biomédica en Red, Instituto de Investigación Sanitaria Aragón, Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili
ORCID: 0000-0001-8160-3716
Observed ORCID: 0000-0001-8160-3716
OpenAlex ID: A5083733947
Low HDL and high triglycerides predict COVID-19 severity
2021 · Lluís Masana, Eudald Correig, et al. · Scientific Reports · 192
PDF
HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk
2019 · Josefa Girona, Núria Amigó, et al. · International Journal of Molecular Sciences · 111
PDF
Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients
2020 · Lluís Masana, Eudald Correig, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 79
PDF
The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario
2019 · Josefa Girona, Cèlia Rodríguez-Borjabad, et al. · Journal of Clinical Medicine · 72
PDF
Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels—The zero-LDL hypothesis
2018 · Luis Masana, Josefa Girona, et al. · Journal of clinical lipidology · 72
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society
2018 · María José Ariza, José Rioja, et al. · Journal of clinical lipidology · 46
Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project
2018 · Daiana Ibarretxe, Cèlia Rodríguez-Borjabad, et al. · Atherosclerosis · 31
PDF
Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain
2019 · Luis Masana, Daiana Ibarretxe, et al. · Atherosclerosis · 28
PDF
Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children
2017 · Josefa Girona, Cèlia Rodríguez-Borjabad, et al. · Journal of clinical lipidology · 25
Glycoprotein Profile Assessed by 1H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study
2020 · Ana-Irene Malo, Anna Rull, et al. · Journal of Clinical Medicine · 23
PDF
Valor de los parámetros lipídicos y apoproteicos para la detección de hipercolesterolemia familiar en la infancia. Proyecto DECOPIN
2018 · Núria Plana, Cèlia Rodríguez-Borjabad, et al. · Clínica e Investigación en Arteriosclerosis · 22
Dietary intake and lipid levels in Norwegian and Spanish children with familial hypercholesterolemia
2020 · Cèlia Rodríguez-Borjabad, Ingunn Narveud, et al. · Nutrition Metabolism and Cardiovascular Diseases · 21
Women with familial hypercholesterolemia phenotype are undertreated and poorly controlled compared to men
2023 · Alberto Zamora, Rafel Ramos, et al. · Scientific Reports · 18
PDF
Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia
2018 · Cèlia Rodríguez-Borjabad, Daiana Ibarretxe, et al. · Atherosclerosis · 14
Serum glycoproteins A and B assessed by 1H-NMR in familial hypercholesterolemia
2021 · Ana-Irene Malo, Josefa Girona, et al. · Atherosclerosis · 13
Glycoprotein Serum Concentrations Assessed By 1H-NMR are Increased in Patients With High Blood Pressure
2022 · Natalia Andreychuk, Dídac Llop, et al. · Hypertension · 12
Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood. The DECOPIN Project
2018 · Núria Plana, Cèlia Rodríguez-Borjabad, et al. · Clínica e Investigación en Arteriosclerosis (English Edition) · 12
Combination therapy in the guidelines: from high-intensity statins to high-intensity lipid-lowering therapies
2022 · Luis Masana, Daiana Ibarretxe, et al. · European Atherosclerosis Journal · 10
PDF
Hipercolesterolemia familiar en la infancia y la adolescencia: una realidad oculta
2017 · Núria Plana, Cèlia Rodríguez-Borjabad, et al. · Clínica e Investigación en Arteriosclerosis · 10
Association between Nordic and Mediterranean diets with lipoprotein phenotype assessed by 1HNMR in children with familial hypercholesterolemia
2023 · Cèlia Rodríguez-Borjabad, Ingunn Narveud, et al. · Atherosclerosis · 7
PDF
Efficacy of therapeutic lifestyle changes on lipid profiles assessed by NMR in children with familial and non-familial hypercholesterolemia
2020 · Cèlia Rodríguez-Borjabad, Ana Irene Malo, et al. · Clínica e Investigación en Arteriosclerosis · 7
Familial hypercholesterolemia in childhood and adolescents: A hidden reality
2017 · Núria Plana, Cèlia Rodríguez-Borjabad, et al. · Clínica e Investigación en Arteriosclerosis (English Edition) · 5
Lipoprotein profile assessed by 1H NMR, BMI and blood pressure are associated with vascular alterations in children with familial hypercholesterolaemia
2023 · D. Llop, A. Feliu, et al. · Nutrition Metabolism and Cardiovascular Diseases · 4
PDF
The Lipoprotein Profile Evaluated by 1H-NMR Improves the Performance of Genetic Testing in Familial Hypercholesterolemia
2024 · Daiana Ibarretxe, Dídac Llop, et al. · The Journal of Clinical Endocrinology & Metabolism · 3
PDF
Massive data screening is a second opportunity to improve the management of patients with familial hypercholesterolemia phenotype
2021 · Alberto Zamora, Guillem Paluzie, et al. · Clínica e Investigación en Arteriosclerosis (English Edition) · 2
Works count: 37
Citation count: 845
H-index: 14
I10-index: 19
Year
Topic
Type